BARCLAYS PLC - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 29 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$141,000
-97.1%
100,000
-97.7%
0.00%
-100.0%
Q3 2016$4,835,000
-12.3%
4,300,000
-14.0%
0.01%
-28.6%
Q2 2016$5,513,000
-49.1%
5,000,000
-50.2%
0.01%
-58.8%
Q1 2016$10,837,000
-22.5%
10,034,000
-10.3%
0.02%0.0%
Q4 2015$13,978,000
+4638.3%
11,182,000
+6044.0%
0.02%
Q3 2015$295,000
-90.3%
182,000
-84.6%
0.00%
-100.0%
Q2 2015$3,038,000
+319.0%
1,182,000
+237.7%
0.00%
+200.0%
Q1 2015$725,000350,0000.00%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Birch Grove Capital LP 7,424,000$7,748,0004.66%
Bruce & Co., Inc. 5,500,000$5,500,0001.26%
IRON Financial LLC 1,025,000$1,066,0000.94%
TENOR CAPITAL MANAGEMENT Co., L.P. 9,291,000$9,812,0000.90%
Sonora Investment Management, LLC 1,430,000$1,495,566,0000.28%
CSS LLC/IL 3,305,000$3,445,0000.17%
FMR LLC 5,100,000$5,247,0000.00%
Allianz Asset Management GmbH 700,000$728,0000.00%
JPMORGAN CHASE & CO 4,365,000$4,605,0000.00%
North Star Investment Management Corp. 1,000$1,0000.00%
View complete list of AMAG PHARMACEUTICALS INC shareholders